{"id":"W2514744353","doi":"10.1016/j.jid.2016.06.408","title":"388 Ixekizumab, a novel anti-IL-17A antibody, exhibits low immunogenicity during long-term treatment in patients with psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ixekizumab; Medicine; Immunogenicity; Titer; Internal medicine; Antibody; Psoriasis; Immunology; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001822883,0.0004417342,0.001001442,0.0004897843,0.0002386832,0.00001819676,0.0004380717,0.0003257991,0.0001122657],"category_scores_gemma":[0.0001949715,0.0002696692,0.0002288637,0.0003413189,0.001233951,0.0004775772,0.00009452343,0.0004036857,0.0000796033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002388578,"about_ca_system_score_gemma":0.0003192603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004981893,"about_ca_topic_score_gemma":0.00001501545,"domain_scores_codex":[0.9973457,0.0003904813,0.001085713,0.0003582495,0.000115569,0.0007042517],"domain_scores_gemma":[0.9980462,0.0002037218,0.001009574,0.0003443227,0.0003604004,0.00003573218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00103891,0.001353251,0.3351274,0.00003919828,0.0006351515,0.0001224403,0.001423619,0.00001328278,0.6582026,0.0001220111,0.00001338792,0.001908746],"study_design_scores_gemma":[0.01165717,0.0004739501,0.6034381,0.0003262797,0.00005960861,0.0006156427,0.0001291649,3.57572e-7,0.382948,0.00004086969,0.00007679492,0.000234103],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952068,0.003025389,0.0001742562,0.0006092089,0.0005214738,0.0003403532,0.00005160441,0.00002403416,0.00004686897],"genre_scores_gemma":[0.9994413,0.0002086264,0.00005853451,0.0001034192,0.000007720495,0.00001175888,0.00003318808,0.00003222339,0.0001032059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2752547,"threshold_uncertainty_score":0.9999756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009113891720477687,"score_gpt":0.2274471785265662,"score_spread":0.2183332868060885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}